TC
EW icon

Trust Company’s Edwards Lifesciences EW Stock Holding History

Trust Company’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$432 Hold
5
– – ﹤0.01% 782
2026
Q2 		$452 Sell
5
-720
-99% -$60.3K ﹤0.01% 783
2026
Q1 		$58.1K Hold
725
– – 0.01% 280
2025
Q4 		$61.8K Sell
725
-205
-22% -$16.8K 0.01% 266
2025
Q3 		$72.3K Buy
930
+720
+343% +$56.3K 0.01% 196
2025
Q2 		$16.4K Hold
210
– – ﹤0.01% 289
2025
Q1 		$15.2K Buy
+210
New +$15K ﹤0.01% 308
2018
Q4 		– Sell
-720
Closed -$42K – 332
2018
Q3 		$42K Hold
720
– – 0.02% 164
2018
Q2 		$35K Hold
720
– – 0.02% 190
2018
Q1 		$33K Hold
720
– – 0.01% 188
2017
Q4 		$27K Hold
720
– – 0.01% 201
2017
Q3 		$26K Hold
720
– – 0.01% 181
2017
Q2 		$28K Hold
720
– – 0.01% 192
2017
Q1 		$23K Hold
720
– – 0.01% 226
2016
Q4 		$22K Hold
720
– – 0.01% 229
2016
Q3 		$29K Sell
720
-720
-50% -$27.1K 0.01% 215
2016
Q2 		$48K Hold
1,440
– – 0.02% 177
2016
Q1 		$42K Hold
1,440
– – 0.02% 180
2015
Q4 		$37.9K Hold
1,440
– – 0.02% 184
2015
Q3 		$34K Hold
1,440
– – 0.02% 203
2015
Q2 		$34K Buy
+1,440
New +$32.5K 0.02% 211

Other funds holding EW

JC
Jacobs & Co San Francisco, California $1.16B AUM 34.03% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $514M AUM 11.69% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
BRCM
Bright Rock Capital Management Hanover, Massachusetts $529M AUM 8.66% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $880M AUM 10.53% 1-Year Est. Return
NRS
Neville Rodie & Shaw New York $1.48B AUM 34.49% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.14B AUM 31.36% 1-Year Est. Return
WPC
Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Trust Company's EW Position: Q3 2026 in Review

Trust Company held its Edwards Lifesciences (EW) position steady in Q3 2026 at 5 shares worth $432. The position accounts for ﹤0.01% of the portfolio, ranked #782.

Trust Company first reported a position in EW in Q2 2015 and has held it in 21 quarters since. The position peaked at $72.3K in Q3 2025. 51 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • Trust Company held 5 shares of Edwards Lifesciences worth $432 as of Q3 2026.
  • Trust Company left its Edwards Lifesciences share count unchanged in Q3 2026.
  • Edwards Lifesciences made up ﹤0.01% of Trust Company's portfolio in Q3 2026, its #782 holding.
  • Trust Company first reported a position in Edwards Lifesciences in Q2 2015 and has held it in 21 quarters since.
  • Trust Company's Edwards Lifesciences position peaked at $72.3K in Q3 2025.
  • 51 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Trust Company's 13F filing for Q3 2026, filed 9 Oct 2026.